TAK
TAKEDA PHARMACEUTICAL CO LTD · Healthcare
Insiders sold $13.1M net in the last 90 days ·13 sellers, 0 buyers· 2 of 18 sales under Rule 10b5-1 plans· latest Form 4 filed Sep 16, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$13.1M
reported sales (SEC code S)
Unique Insiders
13
in the rolling window
Latest filing
Sep 16, 2026
Duprey Lauren Rusckowski
TAKEDA PHARMACEUTICAL CO LTD (TAK) has 52 SEC Form 4 filings (55 transaction rows) in the rolling window, disclosed by 13 distinct insiders. Most recent filing: Sep 16, 2026.
Inside the rolling window, 13 insiders at TAKEDA PHARMACEUTICAL CO LTD reported no open-market purchases and 18 open-market sales totaling $13.1M. The most active filer is President, R&D Plump Andrew Stewart with 3 filings. Insiders have net sold $13.1M over the trailing 6 months. The most recent open-market filing is a sale of 34,535 shares by Chief Transformation Officer Duprey Lauren Rusckowski, dated Sep 14, 2026, worth $640K.
- Industry:Drug Manufacturers - Specialty & Generic
- CEO:Julie So-Young Kim
- Employees:47,029
- HQ:Tokyo, OS, JP
- IPO:2010-01-05
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Transformation Officer | Sale | 34,535 | $640K | Sep 16 | +6.9% | SEC ↗ | |
| President, R&D | Sale | 116,191 | $2.1M | Sep 4 | +8.0% | SEC ↗ | |
| President, R&D | Sale | 19,651 | $363K | Aug 21 | +9.6% | SEC ↗ | |
| Chief Human Resources Officer | Sale | 12,980 | $235K | Aug 19 | +8.7% | SEC ↗ | |
Farajallah Awny Samaan BotrosFirst filing | Chief Medical Officer | Sale | 14,006 | $240K | Aug 13 | +14.6% | SEC ↗ |
Ibrahim Ramy Riad AhmedFirst filing | President, PDT BU | Sale | 7,277 | $124K | Aug 13 | +14.6% | SEC ↗ |
Pacheco Rhonda JaniceFirst filing | President, U.S. Business Unit | Sale | 16,901 | $289K | Aug 13 | +14.6% | SEC ↗ |
Duprey Lauren RusckowskiFirst filing | Chief Transformation Officer | Sale | 47,586 | $814K | Aug 13 | +14.6% | SEC ↗ |
Plump Andrew StewartFirst filing | President, R&D | Sale | 165,393 | $2.8M | Aug 13 | +14.6% | SEC ↗ |
Pignagnoli Agosti MarcelloFirst filing | Head, Strat. & Port. Dev | Sale | 22,957 | $393K | Aug 13 | +14.6% | SEC ↗ |
Bitetti Teresa MarieFirst filing | President, OBU | Sale | 50,012 | $855K | Aug 13 | — | SEC ↗ |
| Pres., Global Supply & Quality | Sale | 3,978 | $68K | Aug 13 | — | SEC ↗ | |
Ricci GabrieleFirst filing | Chief Data & Tech. Officer | Sale | 25,088 | $429K | Aug 13 | — | SEC ↗ |
| Chief Human Resources Officer | Sale | 41,377 | $722K | Aug 13 | — | SEC ↗ | |
Kim Julie So-YoungFirst filing | President and CEO | Sale | 89,090 | $1.5M | Aug 13 | — | SEC ↗ |
Platford Giles RichardFirst filing | President, IBU | Sale | 31,083 | $532K | Aug 13 | — | SEC ↗ |
Furney Natalie Anne MarieFirst filing | Global General Counsel | Sale | 30,868 | $528K | Aug 13 | — | SEC ↗ |
Shannon Elaine MaryFirst filing | Pres., Global Supply & Quality | Sale | 20,363 | $357K | Aug 12 | — | SEC ↗ |
Earnings: last 7 quarters
Congress trading TAK 7 all-time
- RRep. Virginia Ann FoxxSale$15,001 - $50,0002023-08-29
- DRep. Daniel GoldmanSale$15,001 - $50,0002023-07-10
- DRep. Ro KhannaPurchase$1,001 - $15,0002023-03-10
- DRep. Daniel GoldmanPurchase$1,001 - $15,0002023-02-27
- DRep. Ro KhannaPurchase$15,001 - $50,0002023-02-10
- RRep. Virginia Ann FoxxPurchase$1,001 - $15,0002023-02-16
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does TAK have?
TAKEDA PHARMACEUTICAL CO LTD (TAK) has 52 SEC Form 4 filings (55 transaction rows) in the rolling 365-day window, disclosed by 13 distinct insiders. Most recent filing: Sep 16, 2026.
When was the most recent SEC Form 4 filing for TAK?
The most recent Form 4 filing for TAK on Tracefour is dated Sep 16, 2026.
Who is the most active insider at TAK?
The most active SEC Form 4 filer at TAK in the rolling window is President, R&D Plump Andrew Stewart, with 3 filings.
What is the net insider flow at TAK over the last 6 months?
Over the trailing 180 days, insiders at TAK have net sold $13.1M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at TAK in the current window?
Inside the rolling window, insiders at TAK bought $0 and sold $13.1M based on SEC Form 4 filings.
Can I get alerts for TAK insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at TAKEDA PHARMACEUTICAL CO LTD (TAK). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
TAKEDA PHARMACEUTICAL CO LTD is in the Healthcare sector.